Alexander Hardy Biomarin Pharmaceutical Inc (BMRN) insider trading activity

BMRN Quotes by TradingView

Alexander Hardy is Chief Executive Officer of BIOMARIN PHARMACEUTICAL INC. Currently has a direct ownership of 175,583 shares of BMRN, which is worth approximately $12.8 Million. The most recent transaction as insider was on Mar 17, 2025, when has been sold 44,360 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 176K
30.88% 3M change
18.52% 12M change
Total Value Held $12.8 Million

Alexander Hardy Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 17 2025
BUY
Grant, award, or other acquisition
-
44,360 Added 20.17%
175,583 Common Stock
Mar 14 2025
SELL
Payment of exercise price or tax liability
$203,667 $69.44 p/Share
2,933 Reduced 2.19%
131,223 Common Stock
Nov 29 2024
SELL
Payment of exercise price or tax liability
$943,898 $66.03 p/Share
14,295 Reduced 9.63%
134,156 Common Stock
Oct 31 2024
BUY
Grant, award, or other acquisition
$16,803 $56.01 p/Share
300 Added 0.2%
148,451 Common Stock
Mar 15 2024
BUY
Grant, award, or other acquisition
-
32,780 Added 18.12%
148,151 Common Stock
Dec 01 2023
BUY
Grant, award, or other acquisition
-
115,371 Added 50.0%
115,371 Common Stock
AH

Alexander Hardy

Chief Executive Officer
San Rafael, CA

Track Institutional and Insider Activities on BMRN

Follow BIOMARIN PHARMACEUTICAL INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BMRN shares.

Notify only if

Insider Trading

Get notified when an Biomarin Pharmaceutical Inc insider buys or sells BMRN shares.

Notify only if

News

Receive news related to BIOMARIN PHARMACEUTICAL INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BMRN